ADC Therapeutics SA
NYSE:ADCT

Watchlist Manager
ADC Therapeutics SA Logo
ADC Therapeutics SA
NYSE:ADCT
Watchlist
Price: 3.29 USD -7.06% Market Closed
Market Cap: 407.6m USD

Wall Street
Price Targets

ADCT Price Targets Summary
ADC Therapeutics SA

Wall Street analysts forecast ADCT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ADCT is 8.16 USD with a low forecast of 5.05 USD and a high forecast of 10.5 USD.

Lowest
Price Target
5.05 USD
53% Upside
Average
Price Target
8.16 USD
148% Upside
Highest
Price Target
10.5 USD
219% Upside
ADC Therapeutics SA Competitors:
Price Targets
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
38% Upside
IMMX
Immix Biopharma Inc
47% Upside
NIOX
Niox Group PLC
19% Upside
BCAX
Bicara Therapeutics Inc
83% Upside
LENZ
Graphite Bio Inc
101% Upside
MIRM
Mirum Pharmaceuticals Inc
31% Upside
UTHR
United Therapeutics Corp
6% Upside
CRSP
CRISPR Therapeutics AG
41% Upside

Revenue
Forecast

Revenue Estimate
ADC Therapeutics SA

For the last 6 years the compound annual growth rate for ADC Therapeutics SA's revenue is 100%. The projected CAGR for the next 3 years is 29%.

100%
Past Growth
29%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
ADC Therapeutics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
ADC Therapeutics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-35%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ADCT's stock price target?
Price Target
8.16 USD

According to Wall Street analysts, the average 1-year price target for ADCT is 8.16 USD with a low forecast of 5.05 USD and a high forecast of 10.5 USD.

What is ADC Therapeutics SA's Revenue forecast?
Projected CAGR
29%

For the last 6 years the compound annual growth rate for ADC Therapeutics SA's revenue is 100%. The projected CAGR for the next 3 years is 29%.

Back to Top